Friday 6 November 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024.

Revenue: +50.1%
EPS: +147.3%
Free cash flow: +53.5%
Total debt: +0.45%

Quarter to September 2026, against a year earlier

397.03 3.07 −0.77%

Follow MDGL

Alert me

Market cap: $9.3B
P/E: 0.0×
Fwd P/E: −68.8×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	(42.49%)	(49.35%)	(53.31%)	(24.82%)
ROA Full definition →		(25.05%)	(27.83%)	(28.77%)	(11.12%)
ROIC Full definition →		0.00%	(297.52%)	(787.33%)	(1,480.32%)
Return on Tangible Assets Full definition →		(30.77%)	(36.32%)	(38.86%)	(16.42%)
Average Days of Receivables Full definition →		51.21	60.38	54.67	58.12
Free Cash Flow per Share Full definition →		(8.65)	(9.39)	(7.08)	(5.77)
Free Cash Flow Full definition →		(193.99)	(272.61)	(206.28)	(168.65)
Capital Expenditures Full definition →		(4.44)	(4.51)	(8.57)	(11.64)
Other line items
Cash ROIC Full definition →		(10.05%)	(16.02%)	(12.11%)	(8.74%)
Accounts Receivable Turnover Full definition →		10.18	9.10	9.46	8.38
Accounts Payable Turnover Full definition →		1.21	1.53	3.02	2.43
Inventory Turnover Full definition →		1.03	0.94	1.34	1.35
Average Days of Payables Full definition →		317.74	282.77	115.13	173.48
Days of Inventory on Hand Full definition →		486.52	521.21	331.53	346.55
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		40.54%	40.00%	38.17%	27.16%
Selling, General and Administrative Expense of Revenue Full definition →		84.91%	80.75%	78.43%	74.48%
Share Based Compensation of Revenue Full definition →		10.24%	9.82%	9.46%	9.39%
Interest Coverage Full definition →		(13.45)	(11.68)	(10.24)	(4.75)
Operating CF/Net income Full definition →		0.66	0.87	0.61	1.01
Depreciation/Fixed assets Full definition →		4.22	0.83	0.64	0.49
Capex/Depreciation Full definition →		(0.70)	(0.67)	(1.16)	(1.69)
Revenue per Share Full definition →		42.72	39.01	44.05	48.82
Operating CF per Share Full definition →		(8.45)	(9.23)	(6.78)	(5.37)
Capex per Share Full definition →		(0.20)	(0.16)	(0.29)	(0.40)
Capex to Sales Full definition →		0.00	0.00	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly